Our Performance
The Trust aims to be open and honest about how it performs. Below is a selection of Key Performance Indicators with the latest available data:
A&E 4 Hour Wait Target
|
Section Title |
Web Indicator Name |
Month of Achievement |
Achievement |
Target |
Met Or Failed |
|
A&E 4 Hour Wait Target |
Emergency Care 4 Hour Wait |
July 2026 |
75.71% |
82.00% |
Failed |
|
August 2026 |
74.30% |
82.00% |
Failed |
This indicator reports the percentage of patients first seen within two weeks of an urgent GP / GDP referral for suspected cancer. The organisation's performance is measured against a national target of 93 per cent. This indicator is reported one month in arrears.This indicator reports the percentage of A&E attendances where the patient spends four hours or less in A&E from arrival to transfer, admission or discharge. This is a measure against the national waiting time standard, for which the target is 95 per cent.
Cancer
|
Section Title |
Web Indicator Name |
Month of Achievement |
Achievement |
Target |
Met Or Failed |
|
Cancer |
Cancer Faster Diagnosis Overall (1 month in arrears) |
June 2026 |
87.34% |
80% |
Achieved |
|
July 2026 |
87.04% |
80% |
Achieved |
||
|
Cancer 31 Day - Combined (1 month in arrears) |
June 2026 |
96.42% |
94% |
Achieved |
|
|
July 2026 |
96.82% |
94% |
Achieved |
||
|
Cancer 62 Day - Combined (1 month in arrears) |
June 2026 |
72.35% |
80% |
Failed |
|
|
July 2026 |
77.14% |
80% |
Failed |
Cancer: Faster Diagnosis Standard
The Faster Diagnosis Standard target ensures patients with suspected cancer receive a diagnosis, or have cancer ruled out, within a maximum of 28 days from an urgent GP referral. The organisations performance is measured against a national target of 80%. This indicator is reported 1 month in arrears.
Cancer: 31 day diagnosis to treatment cancer target
This indicator reports the percentage of patients receiving their first definitive treatment within one month of a cancer diagnosis. The organisation's performance is measured against a national target of 96%. This indicator is reported 1 month in arrears.
Cancer: 62 days urgent referral to treatment cancer target
This indicator reports the percentage of patients receiving their first definitive treatment for cancer within 62-days of an urgent GP referral for suspected cancer. The organisation's performance is measured against a national target of 85%. This indicator is reported 1 month in arrears.
Infection
|
Section Title |
Web Indicator Name |
Month of Achievement |
Achievement |
Target |
Met Or Failed |
|
Infection |
Healthcare associated incidents of Clostridioides difficile - Cumulative |
July 2026 |
13 |
17 |
Achieved |
|
August 2026 |
18 |
22 |
Achieved |
||
|
MRSA Bacteremia - Trust Acquired - Cumulative |
July 2026 |
2 |
0 |
Failed | |
|
August 2026 |
3 |
0 |
Failed |
||
|
Pressure Ulcers Category 4 - Trust Associated (1 month in arrears) |
June 2026 |
0 |
0 |
Achieved |
|
|
July 2026 |
0 |
0 |
Achieved |
||
|
Pressure Ulcers Moderate Harm - Reportable - Cumulative (1 month in arrears) |
June 2026 |
8 |
15 |
Achieved |
|
|
July 2026 |
10 |
20 |
Achieved |
Infection: MRSA IncidenceThis indicator reports the number of incidences of Clostridium difficile in a calendar month as a cumulative figure per annum. The reporting of Clostridium Difficile rates is set by the SHA (as set out in Section B Part 8.5). By achieving our target, the organisation can demonstrate its standard of practice in relation to Control of Infection, links to quality of patient care and to managing its reputation as a healthcare provider. This can also affect the organisation's registration with the Care Quality Commission.Infection: Clostridium Difficile (Trust acquired)
This indicator reports the total number of new MRSA Bacteraemia in a calendar month cumulatively per annum. The organisation has a target of 0 new incidences per annum. By achieving this target, the organisation can demonstrate the standard of practice in relation to Control of Infection, links to quality of patient care and to managing its reputation as a healthcare provider. Non-achievement can also affect registration with the Care Quality Commission.
Pressure Ulcers Grade 3 & 4
This indicator reports the number of incidences of grade 3 and 4 avoidable pressure ulcers acquired by in patients in the care of the organisation in the calendar month. Monitoring this will encourage best practice in prevention and management for all patients at risk of developing pressure ulcers.
Mortality
|
Section Title |
Web Indicator Name |
Month of Achievement |
Achievement |
Target |
Met Or Failed |
|
Mortality |
HSMR+ - Basket of 41 Diagnosis Groups (4 months in arrears) |
March 2026 |
126.02 |
Relative Risk |
Higher than expected |
|
April 2026 |
140.80 |
Relative Risk |
Higher than expected |
||
|
SHMI - Monthly (6 months in arrears) |
January 2026 |
1.17 |
Relative Risk |
Within expectation |
|
|
February 2026 |
1.18 |
Relative Risk |
Higher than expected |
* HSMR scores are elevated due to the large uncoded backlog at first submission to SUS, we are expecting the score to rebase pending submission of final SUS. This pattern is likely to continue until the uncoded backlog is recovered. Elevated figures should be interpreted with caution.
Mortality: HMSR (Basket of 56 diagnosis Groups)
HMSR stands for Hospital Standardised Mortality Ratio. This indicator reports the comparison of the number of expected deaths (denoted by 100) with the number of actual deaths. This indicator reports the comparison of the number of expected deaths with the number of actual deaths. The data are based on the diagnoses that lead to 80 per cent of all deaths and are adjusted for factors statistically associated with hospital death rates. The trust has a target of 100 or below. This indicator is reported three months in arrears.
Mortality: SHMI
SHMI stands for Summary Hospital-Level Mortality Indicator. The indicator reports how many deaths would be expected to occur if the organisation were like the national average at that point in time (denoted by 100). This indicator reports how many deaths would be expected to occur if the organisation were like the national average at that point in time. The SHMI model takes into account a number of factors such as differences in age, sex, diagnosis, type of admission and other diseases (co-morbidity). The organisation has a target of 100 or below. This indicator is reported quarterly, six months in arrears.
Waiting times
|
Section Title |
Web Indicator Name |
Month of Achievement |
Achievement |
Target |
Met Or Failed |
|
Waiting Times |
Waiting Times: Percentage of Patients Currently Waiting Less than 18 Weeks to Start Treatment (1 month in arrears) |
June 2026 |
57.87% |
67.50% |
Failed |
|
July2026 |
58.30% |
67.50% |
Failed |
This indicator reports the percentage of patients on incomplete pathways within 18 weeks against the total number of patients on an incomplete pathway as at the end of a calendar month. The organisation's performance is measured against a target of 92 per cent. Waiting times: Percentage of incomplete patients seen within 18 weeks.
Staffing levels
Staffing Levels June 2026 unavailable due to technical issues
Staffing levels July, August, September and October 2025 unavailable due to technical issues
Our Values
Compassion
Improve
Learn
Openness
Partnership
Pride
Respect